Targeted drug delivery to the peripheral nervous system using gene therapy

Area of Science:

• Neuroscience
• Gene Therapy
• Pain Management

Background:

• Gene transfer offers targeted delivery of neurotrophic factors for polyneuropathy and neurotransmitters for pain relief.
• Herpes simplex virus (HSV)-based vectors are being explored for gene delivery to sensory neurons.
• Preclinical studies demonstrate efficacy in animal models of various pain conditions and neuropathies.

Purpose of the Study:

• To evaluate the potential of gene transfer for treating polyneuropathy and chronic pain.
• To assess the efficacy of HSV-based vectors for targeted gene delivery in the nervous system.
• To report on the outcomes of early-phase clinical trials for intractable pain.

Main Methods:

• Utilizing non-replicating herpes simplex virus (HSV)-based vectors for gene transfer.
• Injecting vectors into the skin to transduce neurons in the dorsal root ganglion.
• Conducting preclinical studies in animal models and a Phase 1 clinical trial in cancer pain patients.

Main Results:

• HSV-mediated gene transfer demonstrated efficacy in reducing pain behaviors in animal models.
• The approach showed success in preventing sensory neuropathy progression in preclinical studies.
• A Phase 1 clinical trial for intractable cancer pain was successfully completed.

Conclusions:

• Gene transfer with HSV vectors is a promising strategy for targeted treatment of neurological disorders and pain.
• Preclinical and early clinical data support the advancement of HSV-mediated gene therapy for pain and neuropathy.
• Further clinical trials are warranted to explore the full therapeutic potential of this approach.